Meta-analyses demonstrate an intensive upregulation of NEAT1 in several cancer entities, resulting in an unfavorable outcome as well as a drastic decrease in overall survival, suggesting a potential role for NEAT1 as prognostic biomarker [45,46]. Here, NEAT1 is linked to cancer.